Notice of Intent- Essential Support Plan for Thermo Fisher nanoLC-Lumos Mass Spectrometer
ID: 75N95025Q00066Type: Presolicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH NIDABethesda, MD, 20892, USA

NAICS

Electronic and Precision Equipment Repair and Maintenance (811210)

PSC

MAINT/REPAIR/REBUILD OF EQUIPMENT- INSTRUMENTS AND LABORATORY EQUIPMENT (J066)

Original Source

https://sam.gov/opp/f60ef19322d940bca15d1988104f3610/view
Timeline
    Description

    The National Institutes of Health (NIH), specifically the National Institute on Drug Abuse (NIDA), intends to award a non-competitive contract for an Essential Support Plan for the Thermo Fisher nanoLC-Lumos Mass Spectrometer. This procurement aims to secure a service contract for the maintenance and support of the mass spectrometer, which is critical for the operations of the NIH’s Proteomics Core Facility, providing essential protein analysis services. The contract will cover a period from December 10, 2024, to December 9, 2029, ensuring continued functionality of the equipment, as Thermo Fisher is the only authorized provider for these services due to proprietary rights and specialized training of their engineers. Interested parties may submit capability statements to Kelly Dempsey at kelly.dempsey@nih.gov by December 5, 2024, at 12 PM Eastern Time, to be considered for this opportunity.

    Point(s) of Contact
    Kelly Dempsey
    kelly.dempsey@nih.gov
    Files
    No associated files provided.
    Similar Opportunities
    SOURCES SOUGHT: Mass Spectrometer
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking information from qualified small businesses regarding their capabilities to provide a mass spectrometer system for the iPSC Neurodegenerative Diseases Initiative (INDI) Project. The procurement aims to acquire advanced mass spectrometry equipment that will facilitate the measurement of neurodegeneration-related mutations and their effects on protein networks in disease-relevant cells. This equipment is critical for advancing research in neurodegenerative diseases, particularly within the new Center for Alzheimer’s Disease and Related Dementias (CARD). Interested parties must submit their capability statements to Hashim Dasti at hashim.dasti@nih.gov by December 31, 2024, at 11 AM Eastern Time, adhering to specified formatting guidelines and including relevant business information.
    65--Illumina Reagents and Consumables
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Heart, Lung, and Blood Institute (NHLBI), intends to award a non-competitive contract to Illumina, Inc. for the supply of "Illumina Reagents and Consumables" essential for various sequencing and genotyping systems. This procurement is driven by the unique operational needs of NIH-owned systems, as confirmed by market research indicating that only Illumina can provide the proprietary reagents necessary to maintain research integrity and support ongoing studies. The contract performance period is set from September 3, 2025, to September 2, 2030, and interested parties may submit capability statements for review by January 6, 2025; however, this is not a solicitation for proposals. For further inquiries, interested parties can contact Ethan J. Mueller at ethan.mueller@nih.gov or by phone at +1 301 496 2153.
    Support Plan for a Stellaris 8 Confocal Microscope (S/N 8300000444)
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), intends to negotiate a sole-source contract with Leica Microsystems Inc. for a 12-month renewal Support Plan for a Stellaris 8 Confocal Microscope (S/N 8300000444), with two optional one-year extensions. The procurement aims to secure a comprehensive maintenance agreement that includes unlimited service visits by trained engineers, OEM replacement parts, annual planned maintenance, and access to expert support, ensuring the microscope operates at optimal performance levels. This equipment is crucial for research and diagnostics in the field of allergy and infectious diseases, highlighting the importance of maintaining its functionality. Interested vendors must submit capability statements by 10:00 AM EST on December 30, 2024, through the NIAID electronic Simplified Acquisition Submission System (eSASS), with all required documentation to be included for consideration.
    Preventative Maintenance Contract for NICHD Peptide Synthesizer Equipment
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), through the National Institute of Child Health and Development (NICHD), intends to award a non-competitive purchase order to CEM Corporation for a Preventative Maintenance Contract for its peptide synthesizer equipment. This contract is essential for ensuring the operational efficiency of the synthesizer, which is critical for synthesizing peptides used in structural and biochemical research, particularly in studies related to membrane proteins. CEM Corporation, as the sole manufacturer and distributor of the synthesizer in North America, provides specialized technical support and maintenance services that are vital for the continuity of research capabilities. Interested parties may submit their capabilities electronically by January 2, 2025, although this is not a request for competitive proposals. For further inquiries, contact Jacob M. Balenson at jacob.balenson@nih.gov or call 301-827-8302.
    MAINTENANCE AGREEMENT
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to award a non-competitive contract for a maintenance agreement for the Ingenia Elition XProtection MRI machine, crucial for the National Institute of Diabetes, Digestive, and Kidney Disease (NIDDK). The procurement aims to ensure the continuous operation and reliability of the MRI machine through a service agreement that includes preventative maintenance, priority service, and access to necessary spare parts. This contract is vital for maintaining the integrity and usability of the MRI, which is essential for ongoing research and clinical activities. Interested parties should contact Verne L. Griffin at verne.griffin@nih.gov or Michael L. Falzone at michael.falzone@nih.gov, with responses due by 11:00 AM EST on December 27, 2024, under a projected contract value not exceeding $250,000.
    J--NICHD: Service: PacBio Sequel II Service Agreement
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Child Health and Human Development (NICHD), intends to award a sole source contract to Pacific Biosciences of California for a PacBio Sequel II Service Agreement. This procurement is essential for maintaining two advanced PacBio sequencers that are critical for NICHD researchers, ensuring their reliable operation while minimizing downtime and repair costs. The contract will cover one year of service, including preventive maintenance, software updates, remote diagnostics, and the provision of necessary reagents, with a performance period from January 11, 2025, to January 10, 2026, and the possibility of three option years. Interested parties are encouraged to submit their interest and capabilities by December 27, 2024, to determine if a competitive procurement process will be initiated. For further inquiries, contact Nicole T. Freid at nicole.freid@nih.gov or +1 301 480 6914.
    Preventative Maintenance and Service Package for the Mediso nanoScan PET/CT animal imager
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute on Drug Abuse (NIDA), is seeking qualified vendors to provide a Preventative Maintenance and Service Package for the Mediso NanoScan PET/CT animal imager. This procurement involves a comprehensive service plan that includes a 12-month base period followed by four optional 12-month periods, commencing on February 10, 2025, at the Biomedical Research Center in Baltimore, Maryland. The Mediso NanoScan PET/CT is crucial for advanced imaging in biomedical research, and the selected vendor must demonstrate technical capabilities, customer support, and delivery speed as part of the evaluation process. Interested parties should note that the Request for Quotation (RFQ) number is 75N95025Q00104, with responses due by January 6, 2025. For further inquiries, vendors can contact Andrew Varley at andrew.varley@nih.gov or Joshua T. Lazarus at Josh.Lazarus@nih.gov.
    Cytiva Sefia S-2000 Cell Processing Instrument Preventative Maintenance Services
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) intends to award a sole source contract to Global Life Sciences Solutions USA LLC for preventative maintenance services on three Cytiva Sefia S-2000 Cell Processing Instruments located at the NIH Clinical Center in Bethesda, Maryland. The contract will cover unlimited service repair and preventive maintenance for these critical instruments used in cell therapy manufacturing and research, which are essential for compliance with FDA regulations regarding the maintenance of equipment used in drug product manufacturing. Interested parties capable of providing similar services may submit a capability statement by December 29, 2024, at 12:00 pm EST to Sheri Eiri at sheri.eiri@nih.gov for consideration in the procurement process.
    CHROMIUM IX/X AND VISIUM CYTASSIT ASSURANCE PLAN
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking to negotiate a sole-source contract with 10X Genomics, Inc. for a warranty and maintenance agreement for their Chromium X and CytAssist instruments. This procurement is critical as these instruments are essential for conducting advanced single-cell sequencing and spatial transcriptomics research, which supports the development of new diagnostics, therapeutics, and vaccines against human diseases. The maintenance agreement will ensure uninterrupted operation of these technologies, which are vital for NIAID researchers, and interested vendors must submit their capabilities statements via the NIAID electronic Simplified Acquisition Submission System (eSASS) by 12:00 PM EST on December 30, 2024. For further inquiries, vendors can contact Maliaka Pinkney at maliaka.pinkney@nih.gov or Jesse D. Weidow at weidowjd@niaid.nih.gov.
    Global Life Sciences Solutions Preventative Maintenance Services
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to award a sole-source contract for preventative maintenance services for three Sepax Pro Cell Processing Systems used in cell therapy manufacturing and research. The contract will be awarded to Global Life Sciences Solutions USA LLC, the only vendor authorized to perform these services due to the proprietary nature of the equipment and the requirement for compliance with FDA regulations regarding critical equipment maintenance. The period of performance for this contract is set from January 27, 2025, to January 26, 2026, with interested parties encouraged to submit capability statements by December 28, 2024, to Sheri Eiri at sheri.eiri@nih.gov for consideration.